文献速递类风湿关节炎脊柱关节炎

患者发起的DMARD自我监测服务对类风湿或银屑病关节炎的成本效果分析

A patient-initiated DMARD self-monitoring service for people with rheumatoid or psoriatic arthritis: a cost-effectiveness analysis.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该研究在100例使用MTX的RA或PsA患者中开展随机对照试验并同步进行经济评价,比较患者发起的DMARD自我监测服务与常规照护。结果显示,计入热线成本时干预组每例平均费用高263英镑(P<0.001),但患者自付费用有显著节省(P=0.02);结合ESR和SF-12v1质量生命年,该服务未显示具有统计学显著的成本效果。

要点

  • 患者发起的自我监测服务减少了初级和次级医疗服务使用及费用。
  • 计入护士热线成本后,干预组每例平均费用增加263英镑(P<0.001)。
  • 结合ESR和SF-12v1,该服务未达统计学显著的成本效果。

核心结论

  • 患者发起的自我监测服务相比常规照护减少了医疗资源使用和费用,但未显示成本效果。

研究设计与样本

  • 采用英国NHS经济视角计算医疗费用,并对护士电话热线成本进行敏感性分析。
  • 使用 bootstrap 和成本效果平面分析成本效果比值的不确定性。

主要发现

  • 计入热线成本时,干预组每例平均费用高263英镑(P<0.001;95%CI:149.14,375.86英镑)。
  • 热线成本由常规服务吸收时,干预组每例平均费用低94英镑(P=0.08;95%CI:-199.26,10.41英镑)。
  • 患者自付费用有统计学显著节省(P=0.02;95%CI:-28.98,3.00英镑)。
  • 结合ESR和SF-12v1测量的质量生命年,该服务未在统计学显著水平上显示成本效果。

临床怎么用

  • 患者发起的DMARD自我监测可减少医疗资源使用,但需考虑护士热线成本的整合方式。
  • 该模式未显示成本效果,实施前需进一步明确护士电话分诊服务的整合与设置成本。

局限性

  • 经济评价基于英国NHS视角,结果外推需谨慎。
  • 护士热线成本的处理方式影响成本结果,需进一步研究其整合与设置成本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether a patient-initiated DMARD self-monitoring service for people on MTX is a cost-effective model of care for patients with RA or PsA. METHODS: An economic evaluation was undertaken alongside a randomized controlled trial involving 100 patients. Outcome measures were quality of life and ESR assessed at baseline and post-intervention. Costs were calculated for healthcare usage using a United Kingdom National Health Service economic perspective. Sensitivity analysis was performed to explore the impact of nurse-led telephone helplines. Uncertainty around the cost-effectiveness ratios was estimated by bootstrapping and analysing the cost-effectiveness planes. RESULTS: Fifty-two patients received the intervention and 48 usual care. The difference in mean cost per case indicated that the intervention was £263 more expensive (P < 0.001; 95% CI: £149.14, £375.86) when the helpline costs were accounted for and £94 cheaper (P = 0.08; 95% CI: -£199.26, £10.41) when these costs were absorbed by the usual service. There were, however, statistically significant savings for the patient (P = 0.02; 95% CI: -£28.98, £3.00). When costs and effectiveness measures of ESR and quality of life measured, using the Short Form-12v1, were combined this did not show the patient-initiated service to be cost-effective at a statistically significant level. CONCLUSION: This patient-initiated service led to reductions in primary and secondary healthcare services that translated into reduced costs, in comparison with usual care, but were not cost-effective. Further work is needed to establish how nurse-led telephone triage services are integrated into rheumatology services and the associated costs of setting up and delivering them. TRIAL REGISTRATION: ClinicalTrials.gov, http://clinicaltrials.gov, ISRCTN21613721.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. McBain H, Flood C, Shipley M, et al. A patient-initiated DMARD self-monitoring service for people with rheumatoid or psoriatic arthritis: a cost-effectiveness analysis. Rheumatology (Oxford). 2021. PMID: 32734288. doi:10.1093/rheumatology/keaa309

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。